Singapore gets South-East Asia's first accredited cord blood bank:
This article was originally published in Clinica
Executive Summary
The first umbilical cord blood bank in South-East Asia to receive accreditation from the prestigious, non-profit American Association of Blood Banks (AABB) is CordLife, based in Singapore. CordLife is a subsidiary of Australian cell therapy company CyGenics. It is now one of just 35 private and public cord blood banks around the world to have achieved the accreditation from the AABB and the eighth outside the US. The accreditation process, which is a time-consuming and expensive exercise, extends also into non-lab functions such as sales, marketing and HR. It is a globally recognised standard for all operating cord blood banks.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.